Plasma based protein profiling for early stage lung cancer diagnosis
US11769596B2 · kind B2 · utility
0Cited by
11References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2018 |
| Grant date | Sep 26, 2023 |
| Priority date | — |
| Expiry date | Dec 4, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H10/40
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
The invention provides biomarkers and combinations of biomarkers useful in diagnosing non-small cell lung cancer. Measurements of these biomarkers are inputted into a classification system such as Random Forest to assist in determining the likelihood that an individual has non-small cell lung cancer. Kits comprising agents for detecting the biomarkers and combination of biomarkers, as well as systems that assist in diagnosing non-small cell lung cancer are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.